All In Biotech

Free tool

FAERS Monitor: Risperdal

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020588 or its brand name (Risperdal, Risperidone). Reports on generic versions are filed under their own applications.

Reports

121,516

Serious

83,453

69% of reports

Hospitalization

38,138

Death reported

9,507

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • gynaecomastia24,464
  • off label use12,012
  • abnormal weight gain9,410
  • weight increased8,935
  • drug ineffective7,389
  • product use in unapproved indication5,942
  • emotional disorder5,911
  • injury4,618
  • drug interaction4,510
  • hyperprolactinaemia4,424
  • somnolence4,365
  • galactorrhoea3,705
  • obesity3,695
  • emotional distress3,516
  • extrapyramidal disorder3,381

Reports by year received

View as table
YearReports
20042,082
20052,052
20062,349
20072,212
20082,285
20093,901
20103,696
20113,714
20123,761
20133,058
20144,161
201512,643
201613,493
201713,038
20186,712
20197,593
20206,046
20214,893
20225,329
20234,918
20245,290
20254,848
20263,441

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,932,643 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
gynaecomastiaSignal24,464647.9630.83,323,626
abnormal weight gainSignal9,410548.6526.61,229,701
hyperprolactinaemiaSignal4,424369.1350.4516,798
galactorrhoeaSignal3,705234.2223.0364,631
obesitySignal3,69552.050.1141,946
emotional disorderSignal5,91140.839.7185,875
extrapyramidal disorderSignal3,38127.126.273,546
injurySignal4,61812.111.744,065
weight increasedSignal8,9357.27.045,873
emotional distressSignal3,5165.15.011,470
drug interactionSignal4,5105.04.914,274
product use in unapproved indicationSignal5,9424.24.114,456
somnolenceSignal4,3653.83.78,946
off label useSignal12,0122.42.410,028
drug ineffective7,3891.00.97

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.